A research team from Kyushu University in Japan has recently discovered a calcium-based mechanism that plays a key role in ...

A bioinformatics pipeline describes 390 putative, novel inhibitory receptors, to facilitate targeted therapeutic strategies for diverse immune cell types in cancer therapy.

Steven Mansoor, M.D., Ph.D., a physician–scientist at Oregon Health & Science University, and his research team made a ...

PRNewswire Singapore October 5 A new cell therapy targeting CD7 on leukaemia cells gives a potentially effective treatment ...

Discovery could lead to development of new drugs to treat inflammation, coronary artery disease, cancer, more Steven Mansoor, ...

Diffuse large B cell lymphoma (DLBCL) is a cancer that affects white blood cells called B cell lymphocytes. Ordinarily, these cells help protect against infection and disease. In DLBCL ...

Tesla has announced that it produced its 100 millionth 4680 battery cell. Here’s what it means for its production growth. The 4680 battery cell is a new format, 46mm x 80mm, enabled by a few new ...

It shakes and wiggles from within its straitjacket, extending a few fingers to activate a neighboring receptor despite being encased at the surface of the cell. The findings, published on Sept.

B-cell lymphoma is a type of non-Hodgkin's lymphoma (NHL). NHL is a cancer that starts in white blood cells called lymphocytes. Most non-Hodgkin's lymphomas in the United States are B-cell lymphomas.

Diffuse large B-cell lymphoma (DLBCL) stage 4 is an advanced cancer. Despite its aggressive nature, DLBCL usually responds well to treatment, and new therapies are in development to help improve ...

The germinal centre (GC) of lymphoid organs is the main structure where antigen-activated B cells diversify ... receptor CD80 (Ref. 70), which by interaction with its T-cell expressed ligand ...